Shop ATS / ERS Definition, Evaluation and Treatment of Severe Asthma

Definition, Evaluation and Treatment of Severe Asthma

American Thoracic SocietyEuropean Respiratory Society
Published: February 2014
$9.95
Print Copy Information:
  • 16 pages
  • Spiral Bound
  • 80# Aqueous Coating
  • 4.25" x 7.25"
  • Ships in 5 – 10 business days
Add to Cart
What's Inside
Bulk and Institutional Ordering
About the Authors
Additional Information
  • Key Points 
  • Tables 
    • Definition of Severe Asthma for Patients Aged ≥6 Years
    • Definition of High Daily Dose of Various Inhaled Corticosteroids in Relation to Patient Age
    • Diagnosis
    • Diseases Which Can Masquerade as Severe Asthma
    • Diseases Which Can Masquerade as Severe Asthma
    • Comorbidities and Contributory Factors 
    • Recommended Therapies 
    • Quick-Relief Medicines 
    • Inhaled Corticosteroids 
    • Combined Long-Acting Beta Agonist Plus Inhaled Corticosteroid – Comparative Daily Dosages
    • Long-Term Control Medications
  • For purchases under 100 in quantity, we suggest placing the order directly through the website.
  • We offer group/institutional licenses for multi-user accounts (discount amount varies depending on the number of users).
  • We are proud to offer special discounts to medical schools, training programs, students and more.
  • We offer bulk purchase discounts based on number of copies and number of titles.

Contact Us for more details

The roots of the American Thoracic Society reach back to 1905, when a small group of physicians decided that the best way to improve care for tuberculosis patients was to share their experiences and discoveries. Today, the ATS has grown into an international society with more than 15,000 members. In this introductory section, you will find information about the people and programs that make the ATS the world's leading medical association dedicated to advancing our clinical and scientific understanding of pulmonary diseases, critical illnesses and sleep-related breathing disorders.

The European Respiratory Society, or ERS, is a non-profit organization with offices in Lausanne, Brussels and Sheffield.

Description

This resource is for informational purposes only, intended as a quick-reference tool based on the cited source guideline(s), and should not be used as a substitute for the independent professional judgment of healthcare providers. Practice guidelines are unable to account for every individual variation among patients or take the place of clinician judgment, and the ultimate decision concerning the propriety of any course of conduct must be made by healthcare providers after consideration of each individual patient situation. Guideline Central does not endorse any specific guideline(s) or guideline recommendations and has not independently verified the accuracy hereof. Any use of this resource or any other Guideline Central resources is strictly voluntary.

You can also find this product included in this bundle!

ATS Guidelines Bundle

American Thoracic Society
Last Updated: May 9, 2022
$ 300.95 Print Included Guidelines:
  • Definition, Evaluation and Treatment of Severe Asthma
  • Diagnosis and Detection of Sarcoidosis
  • Diagnosis and Treatment of Adults with Community-Acquired Pneumonia
  • Diagnosis of Hypersensitivity Pneumonitis in Adults
  • Diagnosis of Idiopathic Pulmonary Fibrosis
  • Diagnosis of Primary Ciliary Dyskinesia
  • Diagnosis, Risk Stratification, And Management Of Pulmonary Hypertension Of Sickle Cell Disease.
  • Diagnostic Evaluation of Infants with Recurrent or Persistent Wheezing
  • Drug-Susceptible Tuberculosis
  • Ethical and Policy Considerations in Organ Donation after Circulatory Determination of Death
  • Evaluation and Management of Obesity Hypoventilation Syndrome
  • Exercise-induced Bronchoconstriction
  • Fractional Exhaled Nitric Oxide for Asthma
  • Home Oxygen Therapy for Adults with Chronic Lung Disease
  • Home Oxygen Therapy for Children
  • Hospital-acquired and Ventilator-Associated Pneumonia
  • Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in Adults
  • Initiating Pharmacologic Treatment in Tobacco-Dependent Adults
  • Liberation from Mechanical Ventilation in Critically Ill Adults
  • Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease
  • Management of Malignant Pleural Effusions
  • Managing Conscientious Objections in Intensive Care Medicine
  • Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome
  • Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice
  • Noninvasive Ventilation For Acute Respiratory Failure
  • Nucleic Acid-Based Testing for Non-Influenza Viral Pathogens
  • Pediatric Chronic Home Invasive Ventilation
  • Pharmacologic Management of Chronic Obstructive Pulmonary Disease
  • Post-Prematurity Respiratory Disease
  • Prevention and Management of COPD Exacerbations
  • Requests for Potentially Inappropriate Treatments In Intensive Care Units
  • Role of Weight Management in the Treatment of Adult Obstructive Sleep Apnea
  • Routine Lung Function Tests
  • Severe Asthma Management
  • Sleep Apnea, Sleepiness, and Driving Risk in Noncommercial Drivers
  • Treatment of Drug-Resistant Tuberculosis
  • Treatment Of Idiopathic Pulmonary Fibrosis
  • Treatment of Nontuberculous Mycobacterial Pulmonary Disease
  • Tuberculosis Diagnosis Adults and Children
Add to Cart
Need help?